PO.6.141 Efficacy of mycophenolate mofetil (MMF) in pediatric patients with defined and undefined type I interferonopathies

PO.6.141 Efficacy of mycophenolate mofetil (MMF) in pediatric patients with defined and undefined type I interferonopathies

Bibliographic Details
Main Authors:	F De Benedetti, G Prencipe, A Insalaco, C Bracaglia, S Federici, MF Natale, C Udina, CGL Raffaele, V Messia, C Celani
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-10-01
Series:	Lupus Science and Medicine

Similar Items

Mycophenolate mofetil and atherosclerosis
by: Z S Alekberova, et al.
Published: (2009-10-01)

Mycophenolate mofetil in giant cell arteritis
by: Anne Pankow, et al.
Published: (2023-11-01)

Mycophenolate Mofetil and Clostridium difficile-associated Colitis
by: A. I. Dolgushina, et al.
Published: (2021-12-01)

Mycophenolate mofetil–induced hyperlipidemia with cutaneous manifestations
by: Rebecca M. Yim, et al.
Published: (2023-03-01)

Prospects for using mycophenolate mofetil in diffuse scleroderma
by: L P Ananyeva
Published: (2009-03-01)

The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
by: A. Hackl, et al.
Published: (2023-08-01)

Comparison of Benefits and Risks Associated with Anti-T-Lymphocyte Globulin (ATLG) Serotherapy in Methotrexate (MTX)- versus Mycophenolate Mofetil (MMF)-Based Hematopoietic Stem Cell Transplantation
by: Alexander Nikoloudis, et al.
Published: (2023-02-01)

The association of mycophenolate mofetil and human herpes virus infection
by: Jenny Sung Won Yun, et al.
Published: (2020-01-01)

Mycophenolate mofetil for the treatment of autoimmune diseases: hype or hope?
by: Swiss Medical Weekly
Published: (2009-01-01)

Mycophenolate mofetil and mycophenolic acid for the treatment of eosinophilic fasciitis: report of two cases and literature review
by: Ilse Andrea Moreno-Arquieta, et al.
Published: (2022-04-01)

The use of mycophenolate mofetil in treating patients with non responding aplastic anemia
by: Gan, Gin Gin, et al.
Published: (2005)

Mycophenolate mofetil and bronchiectasis in kidney transplant patients: a possible relationship.
by: Rook, M, et al.
Published: (2006)

Management of pemphigoid vegetans with mycophenolate mofetil: A case report
by: Audrey Mathieu, et al.
Published: (2024-02-01)

Mycophenolate mofetil and lichen planopilaris: systematic review and meta-analysis
by: Niyaz Mostafa, et al.
Published: (2022-01-01)

Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis
by: Kevin Phan, et al.
Published: (2020-11-01)

Mycophenolate mofetil therapy in adult patients with recalcitrant atopic dermatitis
by: David Dias-Polak, et al.
Published: (2019-01-01)

Post COVID‐19 organizing pneumonia treated with mycophenolate mofetil
by: Hui Xin Tan, et al.
Published: (2022-11-01)

Recalcitrant vulvar pyoderma gangrenosum successfully treated with mycophenolate mofetil
by: Kelly Z. Young, BA, et al.
Published: (2022-10-01)

1602 Switching from mycophenolate mofetil to mycophenolic acid in SLE patients: Results from the RISE registry
by: Zara Izadi, et al.
Published: (2022-12-01)

Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies
by: C Bandelier
Published: (2009-01-01)

Sex-Specific Responses to Tacrolimus and Mycophenolate Mofetil in Spontaneously Hypertensive Rats
by: Rodrigo Oscar Marañón, et al.
Published: (2023-11-01)

STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA
by: O A Koneva, et al.
Published: (2011-08-01)

Therapeutic outcomes of mycophenolate mofetil and glucocorticoid in thyroid-associated ophthalmopathy patients
by: Lan-Fang Li, et al.
Published: (2023-03-01)

Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune Disease
by: Erin B. Taylor, et al.
Published: (2017-03-01)

Myasthenia Gravis: An Acquired Interferonopathy?
by: Cloé A. Payet, et al.
Published: (2022-04-01)

Type I Interferonopathies in Childhood
by: Fatih Haşlak, et al.
Published: (2023-05-01)

Mycophenolate mofetil-related colitis in a paediatric patient after kidney transplant
by: Natalia Oleksik, et al.
Published: (2022-10-01)

Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies
by: Corrado Campochiaro, et al.
Published: (2024-04-01)

Pharmacokinetics and tolerability of multiple‐day oral dosing of mycophenolate mofetil in healthy horses
by: Kaitlyn Bello, et al.
Published: (2023-09-01)

Two cases of a pharmacokinetic interaction between (val)acyclovir and mycophenolate mofetil
by: F.A. Berger, et al.
Published: (2023-01-01)

Population pharmacokinetics of mycophenolate mofetil in pediatric patients early after liver transplantation
by: Yinyi Wei, et al.
Published: (2022-10-01)

Mycophenolate Mofetil;A Review of Indications and Use in a Large Tertiary Hospital
by: Nimeshan Geevasinga, et al.
Published: (2005-12-01)

Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium with the Concomitant Use of Proton Pump Inhibitors in Patients who Received Kidney Transplant
by: Aysu Selçuk, et al.
Published: (2022-10-01)

Interstitial Lung Disease with Autoimmune Features Successfully Treated with Mycophenolate Mofetil: Case Report
by: Sabrina Khuder, et al.
Published: (2023-12-01)

Mycophenolate mofetil in the treatment of non-renal manifestations of systemic lupus erythematosus: recent insights
by: Ali SAHIN
Published: (2010-05-01)

Immunosuppression by Mycophenolate Mofetil Mitigates Intrarenal Angiotensinogen Augmentation in Angiotensin II-Dependent Hypertension
by: Ryousuke Satou, et al.
Published: (2022-07-01)

Successful Treatment of Mucocutaneous Lupus Erythematosus in a Dog with Prednisolone, Mycophenolate Mofetil and Tacrolimus
by: Jae-Eun Hyun, et al.
Published: (2021-04-01)

Comparative Efficacy and Safety of Mycophenolate Mofetil and Azathioprine in Combination with Corticosteroids in the Treatment of Lymphocytic Myocarditis
by: Olga Blagova, et al.
Published: (2023-07-01)

Mycophenolate mofetil for autoimmune cytopenias in children: high rates of response in inborn errors of immunity
by: Rubén Berrueco, et al.
Published: (2023-10-01)

Mycophenolate mofetil increases the risk of diarrhea in allogeneic hematopoietic stem cell transplantation recipients
by: Liangmo Lin, et al.
Published: (2023-10-01)